ArticleJTCVS techniques2025
Caval translocation as a surgical strategy for patients with congenital heart disease and bilateral superior vena cava.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of neo-innominate connection in bilateral bidirectional Glenn patients using computational flow modeling.JTCVS structural and endovascular · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The presence of bilateral superior vena cava (SVC) may complicate biventricular or single-ventricle pathway surgery. Translocation of an SVC to create a neoinnominate vein may simplify subsequent procedures. Methods: Fourteen patients received an SVC translocation. The longer SVC was translocated, facilitated by complete mobilization of both SVCs, including division of azygos or hemiazygos, and bilateral mammary veins, which increased length and reduced tension on the SVC-SVC anastomosis. Results: Translocation was achieved in 6 patients with commonly corrected defects, in 5 patients to aid in biventricular conversions, and in 3 patients in conjunction with a cavopulmonary anastomosis. At a median follow-up of 1.3 years (range, 2 weeks to 7.1 years), there were no translocation-related deaths or evidence of impaired superior systemic venous return. Conclusions: For patients with bilateral SVCs, translocation is a valuable addition to the armamentarium of strategies and holds promise for facilitating biventricular repair. Moreover, for patients requiring cavopulmonary anastomosis, a translocation enables a single cavopulmonary connection, and future studies may prove this strategy to be optimal over the traditional bilateral cavopulmonary connection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.